Artem Cherkasov and Olexandr Isayev on Democr...

Instacart has 1.6 billion lifetime grocery orders—and is now using that data flywheel to digitize the physical store itself. In this episode, David McIntosh, Chief Connected Stores Officer at Instacart, explains how the Caper Cart—powered by an NVIDIA Jetson™ board and a sensor f ...  Show more

Open-weight models are closing the gap with proprietary AI — and Timothée Lacroix, cofounder and CTO of Mistral, has been betting on that since day one. In this episode, he explains why open weights accelerate enterprise adoption, how Mistral is bringing model customization into ...  Show more

Why is the process of creating a new and highly beneficial pharmaceutical drug so difficult? What are the hurdles researchers face when trying to identify a new drug? Why are side effects so challenging to predict? Why are pharmaceutical drugs so expensive? In today's episode, we ...  Show more

It’s widely assumed that drug treatment is a miracle of modern science. However, it’s equally arguable that modern drug treatment is a very expensive disaster, with serious consequences for public health. For example, a drug typically takes 10-12 years to develop and the cost is ...  Show more

In this episode, we delve into how DeepMind's newest iteration of the AlphaFold model is revolutionizing the field of drug discovery. Explore the breakthroughs and potential applications that this cutting-edge technology brings to the pharmaceutical world. Invest in AI Box: https ...  Show more

In this episode, we delve into Nvidia's substantial $50M investment in Recursion, a leading firm in AI drug discovery. We'll explore the strategic implications of this partnership, discuss how it might accelerate the application of AI in pharmaceutical research, and consider its ...  Show more